期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胰腺癌生物治疗的新靶点：MUC1

原文传递
导出
摘要 胰腺癌预后很差，消耗着巨大的社会卫生资源。目前对胰腺癌的治疗仍缺乏有效的治疗手段。65％胰腺癌病人在诊断明确后半年内死亡，约90％的病人一年内死亡。探索新的有效的治疗方法，是目前急需解决的重要课题。生物治疗，尤其是肿瘤疫苗，作为具有临床应用潜力和价值的治疗手段，近年来开始得到了深入的研究。其关键是选择有效的治疗靶点，即寻找合适的肿瘤相关抗原（tumor associate antigen，TAA）。
作者 吴文川 靳大勇
机构地区 复旦大学附属中山医院普外科胰腺组
出处 《中华肝胆外科杂志》 CAS CSCD 2007年第12期862-864,共3页 Chinese Journal of Hepatobiliary Surgery
关键词 胰腺癌病人 生物治疗 MUC1 新靶点 社会卫生资源 肿瘤相关抗原 治疗方法 肿瘤疫苗
分类号 R735.9 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1Freelove R, Walling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician, 2006, 73: 485-492.
  • 2Zalatnai A. Pancreatic cancer-a continuing challenge in oncology. Pathol Oncol Res, 2003, 4: 252-263.
  • 3Rosenberg L, Lipsett M. Biotherapeutic approaches to pancreatic cancer. Expert Opin Biol Ther, 2003, 3:319-337.
  • 4Burke PA, Gregg JP, Bakhtiar B, et al. Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules. Int J Oncol, 2006, 29:49-55.
  • 5Rajabi-Memari H, Jalali-Javaran M, Rasaee MJ, et al. Expression and characterization of a recombinant single-domain monoclonal antibody against MUC1 mucin in tobacco plants. Hybridoma (Larchmt), 2006, 25 : 209-215.
  • 6Dwyer RM, Bergert ER, O'Connor MK, et al. Adenovirus-mediated and targeted expression of the sodium iodide symporter permits in vivo radioiodide imaging and therapy of pancreatictumors. Hum Gene Ther, 2006, 17:661-668.
  • 7Schmitz-Winnenthal FH, Volk C, Z'graggen K, et al. High frequencies of functional tumor-reactive T cells in bone mar row and blood of pancreatic cancer patients. Cancer Res, 2005, 65:10079-10087.
  • 8Lan MS, Batra SK, Qi WN, et al. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem, 1990, 265: 15294-15299.
  • 9Apostolopoulos V, McKenzie FC. Cellular mucins: Targets for immunotherapy. Crit Rev Immunol, 1994,14 : 293.
  • 10Price MR, Rye PD, Petrakou E, et al. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumour Biol, 1998, 19:1-20.

二级参考文献30

  • 1Yeo CJ. Pancreatic cancer- 1998 Update.J Am Coil Surg, 1998, 187:429-442.
  • 2Rosenberg L, Lipsett M. Biotherapeutic approaches to pancreatic cancer. Expert Opin Biol Ther, 2003, 3 : 319-337.
  • 3Goydos JS, Elder E, Whiteside TL, et al. A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma. J Surg Res, 1996, 63 : 298-304.
  • 4Apostolopoulos V, Pieterz GA, Xing PX, et al. The immunogenicity of MUC1 peptides and fusion protein. Cancer Lett, 1995, 90:21-26.
  • 5Brossart P, Heinrich KS, Stuhler G, et al. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood, 1999, 93:4309-4317.
  • 6Brossart P,Heinrich KS,Stuhler G,et al.Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.Blood,1999,93:4309-4317.
  • 7Johnen H,Kulbe H,Pecher G.Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1).Cancer Immunol Immunother,2001,50:356-360.
  • 8Roden MM,Lee KH,Panelli MC,et al.A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology.J Immunol Methods,1999,226:29-41.
  • 9Yeo CJ.Pancreatic cancer-1998 Update.J Am Coll Surg,1998,187:429-442.
  • 10Rosenberg L,Lipsett M.Biotherapeutic approaches to pancreatic cancer Expert Opin Biol Ther,2003,3:319-337.

共引文献19

中华肝胆外科杂志
2007年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部